WHO Issues Best Practice Guide For Counterfeit Drug Detection
WHO heeds the call of member states and issues guide on standard operating procedures for labs to follow in testing suspected counterfeit drug products. A majority of survey respondents had told WHO that drug counterfeiting is a major problem within their territories and that such a guidance is needed.
You may also be interested in...
The World Health Organization is holding a further consultation on draft guidance on the testing and reporting of suspected falsified medicines.
The US FDA and NIST have agreed to help industry modernize and update pharmaceutical manufacturing methods and to improve supply chain resilience.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.